Hosseini, Adele

Dr Adele Hosseini

Chief Scientific Officer, Bod; Clinical Trial Developer; University Lecturer
Dr. Adele Hosseini has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues the strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications.

More from this expert

Medicinal cannabis is an unregistered medication that is widely prescribed and used

Podcasts iconPodcasts

We invite you to join the upcoming Healthed webcast where we will focus on working through the popular management myths and misperceptions in general practice with the aim of improving patient outcomes and quality of life.

Tuesday 19th August, 7pm AEST